pyrazines has been researched along with Merkel Cell Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arora, R; Brodsky, JL; Chang, Y; Dömling, A; Feng, H; Guastafierro, A; Moore, PS; Normolle, D; Shuda, M; Tolstov, Y; Toptan, T; Vogt, A; Vollmer, LL | 1 |
1 other study(ies) available for pyrazines and Merkel Cell Cancer
Article | Year |
---|---|
Survivin is a therapeutic target in Merkel cell carcinoma.
Topics: Animals; Antigens, Viral, Tumor; Antineoplastic Agents; Base Sequence; Boronic Acids; Bortezomib; Carcinoma, Merkel Cell; Cell Line, Tumor; Female; Gene Expression Profiling; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; Merkel cell polyomavirus; Mice; Mice, Inbred NOD; Mice, SCID; Naphthoquinones; Polyomavirus Infections; Pyrazines; RNA, Messenger; RNA, Neoplasm; Survivin; Translational Research, Biomedical; Tumor Virus Infections; Xenograft Model Antitumor Assays | 2012 |